Explore more publications!
Aruba Science Wire
Got News to Share?

Aruba Science Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 19, 2025

Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses
December 19, 2025

Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses

Indeterminate GlobeNewswire
Outlook Therapeutics Reports Financial Results for Fiscal Year 2025
December 19, 2025

Outlook Therapeutics Reports Financial Results for Fiscal Year 2025

Indeterminate GlobeNewswire
VyOS Networks Announces VyOS 1.4.4 LTS Release, Reinforcing the Universal Networking Platform for Hybrid Cloud and Edge
December 19, 2025

VyOS Networks Announces VyOS 1.4.4 LTS Release, Reinforcing the Universal Networking Platform for Hybrid Cloud and Edge

Indeterminate GlobeNewswire
Siskinds LLP and Berger Montague (Canada) PC announce: NOTICE OF SETTLEMENT - DID YOU ACQUIRE SHARES OF JUST ENERGY GROUP INC. BETWEEN MAY 16, 2018 AND AUGUST 14, 2019 (INCLUSIVE)?
December 19, 2025

Siskinds LLP and Berger Montague (Canada) PC announce: NOTICE OF SETTLEMENT - DID YOU ACQUIRE SHARES OF JUST ENERGY GROUP INC. BETWEEN MAY 16, 2018 AND AUGUST 14, 2019 (INCLUSIVE)?

Indeterminate GlobeNewswire
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
December 19, 2025

Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis

Indeterminate GlobeNewswire
Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027
December 19, 2025

Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027

Indeterminate GlobeNewswire
AirJoule Technologies Partners with Red Dot Ranch to Advance Residential Off-Grid Water Solutions in California’s Coastal Communities
December 19, 2025

AirJoule Technologies Partners with Red Dot Ranch to Advance Residential Off-Grid Water Solutions in California’s Coastal Communities

Indeterminate GlobeNewswire
Airia Achieves AWS Validated Partner Status Strengthening Enterprise AI Security and Deployment Capabilities for AWS Customers
December 19, 2025

Airia Achieves AWS Validated Partner Status Strengthening Enterprise AI Security and Deployment Capabilities for AWS Customers

Indeterminate GlobeNewswire
Aduro Clean Technologies Announces Pricing of US$20 Million Underwritten Public Offering
December 19, 2025

Aduro Clean Technologies Announces Pricing of US$20 Million Underwritten Public Offering

Indeterminate GlobeNewswire
Cue Biopharma Announces Pricing of $10 Million Public Offering
December 19, 2025

Cue Biopharma Announces Pricing of $10 Million Public Offering

Indeterminate GlobeNewswire
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
December 19, 2025

IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager

Indeterminate GlobeNewswire
TeleAI Unveils Breakthrough Metric to Quantify AI “Talent” in Large Language Models
December 19, 2025

TeleAI Unveils Breakthrough Metric to Quantify AI “Talent” in Large Language Models

Indeterminate GlobeNewswire
Rezolve Ai to Host Analyst and Investor Call on January 13, 2026 to Provide Updated 2025 and 2026 Revenue Guidance
December 19, 2025

Rezolve Ai to Host Analyst and Investor Call on January 13, 2026 to Provide Updated 2025 and 2026 Revenue Guidance

Indeterminate GlobeNewswire
Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update
December 19, 2025

Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update

Indeterminate GlobeNewswire
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
December 19, 2025

Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2

Indeterminate GlobeNewswire
OKYO Pharma to Ring the Opening Bell at Nasdaq
December 19, 2025

OKYO Pharma to Ring the Opening Bell at Nasdaq

Indeterminate GlobeNewswire
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
December 19, 2025

Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial

Indeterminate GlobeNewswire
Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial
December 19, 2025

Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial

Indeterminate GlobeNewswire
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
December 19, 2025

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Indeterminate GlobeNewswire
BEN born in Portugal to be driven across Europe
December 19, 2025

BEN born in Portugal to be driven across Europe

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions